A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
Clinical trial NCT05804383 · COMPLETED
Trial details
- NCT number
- NCT05804383
- Sponsor
- Allyx Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2025-07-15
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.